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A bioreactor and methods of using same for making tissue 
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and harvested tissues such as cryopreserved tissues. The 
bioreactor allows for static and dynamic culture/condition-
ing. The bioreactor is dual chambered (one chamber above 
and one below the cells or construct) to allow for application 
of biochemical and/or biomechanical stimuli to each side of 
the cells/construct. 
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BIO REACTOR AND METHODS FOR TISSUE 
GROWTH AND CONDITIONING 
CROSS-REFERENCE TO RELATED 
APPLICATION 
This application claims priority to U.S. Provisional Appli-
cation Ser. No. 60/450,443, filed on Feb. 26, 2003. 
2 
this way may accelerate the repair of defects involving tissue 
interfaces such as osteochondral defects. 
Functional tissue engineering of cartilage involves the use 
ofbioreactors designed to provide a controlled in vitro envi-
ronment that embodies some of the biochemical and biome-
chanical stimuli known to regulate chondrogenesis. Various 
types ofbioreactors have been investigated for use in produc-
ing tissue-engineered human cartilage, including rotating-
wall vessels, spinner flasks, perfusion, and compression/per-
STATEMENT REGARDING FEDERALLY 
SPONSORED RESEARCH 
This invention was made with govermnent support under 
grant number EEC-9731643 awarded by National Science 
Foundation. The Government has certain rights in the inven-
tion. 
10 fusion bioreactors. In each type of reactor the flow of the 
culture medium causes the growing tissue to experience a 
different dynamic environment, potentially influencing the 
character of the final tissue. Three main types of forces are 
currently used in cartilage-culturing processes: hydrostatic 
15 pressure, direct compression, and shear fluid environments. 
BACKGROUND OF THE INVENTION 
Prior art bioreactors provide the cells or construct with a 
single culturing or conditioning environment. It would be 
advantageous to have a bioreactor wherein biochemical and 
biomechanical stimuli can be applied to each side of a con-
The invention is generally in the field of tissue engineering, 
more specifically in the field of growth and conditioning of 
tissue constructs. With the American public aging and sports-
related injuries increasing, the demand for orthopedic surger-
20 struct. Such a bioreactor, where the biochemical and biome-
chanical stimuli are different on each side, could result in a 
heterogeneous construct. Thicker constructs could result with 
the use of the same stimuli applied to both sides of the con-
struct. ies has grown tremendously. In 1998, there were over 3 mil-
lion people afflicted with such problems in the United States 25 
alone, representing both a significant clinical problem and 
commercial opportunity. Currently, a great deal of research is 
being devoted to restoring function in damaged orthopedic 
tissues. Restoration of function to damaged orthopedic tis-
sues has taken many forms: autografts, allografts, xenografts, 30 
implantable (permanent and biodegradable) biomaterials, 
and tissue-engineered constructs. Each of these treatments 
has achieved some degree of success, but each has its limita-
tions. 
Two of the more attractive solutions which have recently 35 
emerged are allografts and tissue-engineered constructs. An 
allograft is a tissue transplanted between individuals of the 
same species. Allografts relieve some of the burden of a 
supply source, while tissue-engineered constructs can in 
theory be a complete off-the-shelf solution. Tissue engineer- 40 
ing of cartilage constructs grown in vitro has emerged as a 
potentially more suitable treatment than allografts. However, 
either of these solutions will prove to be commercially viable 
only if the construct or allograft can restore function. Resto-
ration of function is more likely if the implanted tissue pos- 45 
sesses: 1) an active cellular component to facilitate remodel-
ing, 2) similar biomechanical properties to sustain load-
bearing movements, and 3) an ability to properly integrate 
into the host tissue for a sustained, long-term maintenance of 
function. 50 
The orthopedic tissues in the body receive biomechanical 
stimulation; in particular, long bones, articular cartilage, and 
the meniscus are constantly being loaded. Prior to implanta-
tion in the body, ex vivo cultured tissues often lack the proper 
mechanical properties or cellular function to become fully 55 
integrated and functional. One approach to improving this 
deficiency is to subject the tissue to similar biomechanical 
loads as seen in situ, such as shear stress, prior to implanta-
tion. Reduced cellular function may also be addressed 
through exposure to biochemical stimuli such as growth fac- 60 
tors. A combination of biochemical and biomechanical 
stimuli may be most desirable. 
Integration of a construct may be better if it is heteroge-
neous; that is, the type of cells or characteristics of the cells 
varies across the construct. For example, a construct could 65 
have cartilage-like tissue on one side and bone-like tissue on 
the other side. Mimicking the native tissue heterogeneity in 
SUMMARY OF THE INVENTION 
The Invention is a bioreactor (and methods of using same) 
for making tissue constructs and for conditioning tissue-en-
gineered constructs and harvested tissues such as cryopre-
served tissues. The bioreactor is dual chambered (one cham-
ber above and one below the cells or construct) to allow for 
application of biochemical and/or biomechanical stimuli to 
both sides of the cells or construct. Different stimuli can be 
applied to each side, desirably resulting in a heterogeneous 
construct. The bioreactor allows for static and dynamic cul-
ture/conditioning. 
The bioreactor can be used for growth of cells into a tissue 
construct. The bioreactor can also be used for the biochemical 
and/or biomechanical conditioning of tissue-engineered con-
structs or harvested tissues, such as cryopreserved tissue 
(both referred to herein as "constructs" or "tissue"), prior to 
implantation. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 is an exploded perspective view of one embodiment 
of the bioreactor in the "perfusion" configuration, having a 
cap, top plate, frame, and bottom plate. 
FIG. 2 is a schematic of the bottom surface of the top plate. 
FIG. 3 is a schematic of the bottom surface of the cap. 
FIG. 4 is an exploded perspective view of the cover and top 
plate. 
DETAILED DESCRIPTION OF THE INVENTION 
As used herein, the term "construct" refers to tissue formed 
in a bioreactor, generally by cells proliferating and secreting 
extracellular matrix, tissue formed ex vivo by other means, or 
harvested tissue. 
The term "substrate" refers to a two dimensional mem-
brane or three dimensional scaffold to which cells can attach. 
The invention is a bioreactor and methods for using the 
bioreactor for growth of cells on a substrate or for condition-
ing of tissue constructs. The bioreactor has a dual chamber 
design and means for applying biomechanical stimuli to the 
cells or construct. The dual chamber design allows for expo-
US 7,416,884 B2 
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sure of both sides of the cells or construct to biochemical and 
biomechanical stimuli. The bioreactor also allows for expo-
sure of each side of the substrate or construct to different 
biochemical or biomechanical stimuli. The dual chamber 
design thus allows for feeding of cells above and below a 
membrane, for example, which increases the overall mass 
transport to the cells or construct because the available sur-
face area is larger. As another example, the dual chamber 
design allows for application of shear stress to the top of a 
construct while the bottom of the construct is exposed to a 
growth factor. 
The dual chamber design allows for introduction of het-
erogeneity in the tissue. Different cell types can be seeded and 
grown in the two chambers. Or cells of the same type can be 
exposed to different media, i.e. different growth factors or 
different amounts of a growth factor. A gradient of cellular 
phenotype should aid in integration of the construct into an 
implantation site. Examples are a cartilage-to-bone or peri-
osteum-to-bone construct for implantation into a site com-
prising both cartilage and bone, or periosteum and bone. 
The bioreactor allows for the application of both biochemi-
4 
plurality of diffusion ports 42 along their length in the region 
of the tube which extends into the region of the bottom plate 
within the gasket 32. 
Cap 18 is illustrated in FIG. 1 and in more detail in FIG. 3, 
which is a view of the bottom surface of cap 18. Cap 18 has a 
protrusion 44 extending from its bottom surface, having a 
surface area slightly smaller than that of the top plate cut out 
region 20. The protrusion 44 has two lateral diffusion grooves 
46 on its bottom surface. Cap 18 has an inlet port 48 and an 
10 outlet port 50, and a tube 54 or 56 that passes through the cap 
18 and connects the port to a diffusion groove 46. 
FIG. 4 illustrates cover 52, which fits over top plate 12 for 
the use of the bioreactor in static mode, as explained below. 
Each of cap 18, cover 52, top plate 12, frame 16, and 
15 bottom plate 14 can be made of a variety of materials. It is 
important that the material not interfere with cell growth or 
construct conditioning. Exemplary materials are metals such 
as stainless steel and aluminum (with anodization), and plas-
tics such as Plexiglas, polystyrene, polycarbonate, and poly-
20 tetrafluoroethylene (PTFE). In a preferred embodiment, the 
cap, cover, and top and bottom plates are made from clear 
polycarbonate and the frame is stainless steel. The gaskets can 
be made from silicone rubber. 
cal and biomechanical stimuli. In a preferred embodiment 
illustrated in the Figures, biochemical stimuli, in the form of 
growth factors, can be applied to the top and bottom faces on 25 
the construct. Biomechanical stimuli, in the form of shear 
stress, can be applied to the top face in laminar flow in the 
parallel-plate flow chamber. 
Cell Substrates-Membranes and Scaffolds 
The membrane can be made of a variety of materials that 
are suitable for cell growth and construct conditioning. The 
material is ideally biocompatible and sterilizable. The mem-
brane can be made of a permanent or biodegradable/biore-The bioreactor can be used for growth of cells into a tissue 
construct. The bioreactor can also be used for the biochemical 30 
and/or biomechanical conditioning of both tissue-engineered 
constructs and harvested tissues, such as cryopreserved tis-
sue. 
sorbable natural or synthetic polymer, can be porous or non-
porous, permanent or biodegradable, and can have a variety of 
pore diameters, from 0.01 micron up to approximately 8 to 10 
microns. 
Cell growth membranes are well known in the art. I. The Device 
The bioreactor 10 is shown in FIG. 1 in the configuration 
used for dynamic growth or conditioning, also referred to as 
the perfusion mode. The bioreactor includes a top plate 12 and 
a bottom plate 14, having frame 16 there between. The biore-
actor further includes cap 18. 
35 
Examples of biodegradable materials from which the mem-
brane can be made are poly-E-caprolactone, polyesters, poly-
lactides, polyvinyl alcohols, polyglycolides, polyolefins, and 
polyanhidrides. Non-biodegradable materials which can be 
used as a membrane include nitrocellulose, cellulose ester, 
The bottom surface of top plate 12 is shown in FIG. 2. Top 
plate 12 has a cut-out region 20 which extends through the 
plate. Surrounding the cut out region is a gasket 22. Top plate 
12 further includes a plurality of fastening holes 24 which 
may be threaded. As shown in FIG. 1, cap 18, frame 16, and 
bottom plate 14 also have a plurality of holes 24. A fastening 
screw, for example, (not shown) can be inserted through the 
holes of each part to hold the device together. 
40 
nylon, polypropylene, polyvinylchloride, and their deriva-
tives. In one embodiment the membrane is a thin (10 micron) 
semipermeable (0.2 micron) polycarbonate membrane. 
A scaffold is a three dimensional framework that allows 
attachment and growth of cells. A scaffold can be used in the 
45 device, in addition to or instead of the membrane, to provide 
a structure for the cells to grow upon. The scaffold can be 
made of the same types of materials as recited for the mem-
brane above. Such scaffolds are known in the art. 
As illustrated in FIG. 1, frame 16 contains a cut-out region 
26 desirably the same size as the cut out region 20 of the top 50 
plate. A membrane 28 is attached to the side of frame 16 
facing the top plate 12 and covers the cut out region 26. The 
membrane can be attached to the frame by a variety of means. 
As discussed further below, the bioreactor can be used in 
dynamic mode to condition the construct that has been 55 
formed in the bioreactor. If the bioreactor is used to condition 
a construct that has not been formed within the bioreactor, 
such as a cryopreserved tissue, the construct may be attached 
Size 
The size of the bioreactor can vary and will be selected 
according to the size of the construct to be grown or condi-
tioned. The membrane area or scaffold size will also vary 
depending upon the size of the construct to be grown or 
conditioned. Generally, implanted constructs will range from 
about 1 to 5 mm in diameter and be 1 to 3 mm thick. Multiple 
punches for implantation can be taken out of one construct if 
desired. In one embodiment, the flow chamber is 1.8 inches 
long and 0.5 inches wide and the growth area is 5.8 cm2 (a 
clinically relevant size for orthopedic implants). The dimen-to a frame not having a membrane attached thereto. Alterna-
tively, the construct may be placed on top of or secured to the 
membrane. Desirably, the placement of the construct main-
tains the separateness of the chambers. 
60 sions of the flow chamber, along with flow rate, are variables 
in the shear stress that can be achieved, as discussed below. 
Bottom plate 14 is shown in FIG. 1. The plate includes an 
indented region 30 into which a bottom plate gasket 32 fits. 
Bottom plate has two ports-an inlet 34 and outlet 65 
36-which provide access to an inlet tube 38 and outlet tube 
40, respectively. These inlet and outlet tubes each have a 
The bioreactor is scaleable so long as the fluid dynamics 
are kept the same. This would likely require additional ports 
(and perfusion lines, etc.) if the width was increased. The 
length can be increased without any significant redesign; 
however, a decrease in length would alter the fluid dynamics. 
II. Assembly and Operation 
US 7,416,884 B2 
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As further explained below, the bioreactor can be used in 
both a static mode and a dynamic, or perfusion, mode. Static 
mode is used for growth of cells or tissue without the influ-
ence of mechanical forces. In perfusion mode, the device is 
capped, creating a defined fluid chamber above the cells or 
construct, through which media can be pumped, for example 
using a peristaltic pump and tubing (not shown). 
For static growth or conditioning, the cap is not used, 
instead the bioreactor is topped with the cover 52. After the 
membrane 28 is selected and fastened to the frame 16, the 10 
bottom plate 14, frame 16, and top plate 12 are stacked in 
order. Screws or other fastening elements (not shown) are 
used with the fastening holes 24 to fasten the three parts 
together. After placing the cells in the top chamber (see more 
below), the cover52 is placed over the top plate 12. The cover 15 
52 desirably does not seal the top plate 12, it simply provides 
protection from contaminants. 
It can be appreciated from the description that a bottom 
chamber is defined by the bottom plate 14, the walls of the cut 
out part 26 of the frame 16, and the membrane 28. A top 20 
chamber is defined by the membrane 28, the top plate gasket 
22, and cover 52 or cap 18. Gaskets 32 and 22 provide a 
liquid-tight seal between bottom plate 14 and frame 16 and 
top plate 12 and frame 16, respectively. 
The cells are cultured in the bioreactor for the desired 25 
6 
achieved by varying the flow rate and chamber size (assuming 
the media viscosity is a constant). A desirable shear stress is 
generally from about 1 to 100 dynes/cm2 , more desirably 
from about 10-20 dynes/cm2 . Since different cells respond 
very differently to different ranges of shear stress, the amount 
of stress will be varied depending on the cell type being 
cultured. 
Cells 
Any adherent cell type can be grown in the bioreactor; i.e. 
undifferentiated cell types such as mesenchymal stem cells, 
or differentiated cell types such as chondrocytes, osteoblasts, 
fibroblasts across many lineages. In a preferred embodiment, 
bovine articular chondrocytes are grown from high-density 
mono layer into a tissue resembling native articular cartilage. 
Different cells can be seeded in the top and bottom chambers 
and different cells can be seeded in layers during sequential 
seedings. 
Tissue Constructs 
The bioreactor can be used to condition tissue constructs 
that have just been grown in the bioreactor in static mode. It 
can also be used to condition tissue-engineered constructs 
made elsewhere and harvested tissues such as autografts, 
allografts, or xenografts. For example cryopreserved tissues 
such as meniscal allografts may be preconditioned within the 
bioreactor to improve cell viability and synthetic activity 
prior to implantation. A combination approach may also be 
taken in which cells are seeded onto cryopreserved tissues to 
enhance their cellularity prior to implantation. Enhanced cel-
period of time, commonly about 2 to 4 weeks but this can 
vary. Depending on the original cell density, the cells could be 
cultured infinitely long. Eventually, they would reach a 
steady-state and would simply require nutrient replenish-
ment. However, cells are generally not cultured in static cul-
tures longer than about two months. Fresh media can be 
placed in the top chamber and the same or different media can 
30 lular function either within or on the surface of cryopreserved 
tissues may accelerate allograft integration and remodeling 
following implantation. 
be placed in the bottom chamber and circulated through the 
bottom chamber, if desired, using ports 34 and 36. Cells can 
also be seeded into the bottom chamber if desired. Reseedings 35 
can be done, if desired, to build layers of different types of 
cells, for example. 
For perfusion, and application of shear stress, the cover 52 
is removed and the cap 18 is fastened to the top plate 12 with 
the fastening elements as described above with respect to the 40 
plates 12, 14 and the frame 16. A shim (not shown in the 
figures) made of plastic or metal, can be placed between the 
cap 18 and the top plate 12 if desired. 
Biochemical Stimuli 
Biochemical stimuli in the form of soluble growth factors 
can be used, depending on the cell type. For instance, to 
encourage chondrogenesis, factors like transforming growth-
factor beta (TGF-~), fibroblast growth factor (FGF), insulin-
like growth factor (IGF), and ascorbic acid can be used. An 
osteogenic factor such as dexamethasone, a bone morpho-
genic protein (BMP), vitamin D, or parathyroid hormone 
(PTH) can also be used. Other factors can be used based on 
the appropriateness for the cell type or intended function 
(growth/expansion versus differentiation). 
Biomechanical Stimuli 
As discussed above, fluid induced shear stress and direct 
mechanical stress are biomechanical stimuli that can be 
applied to cells or constructs to induce certain characteristics 
in the cells or construct. Flow stimulation may be continuous, 
periodic, or oscillating. Shear stress may be modulated by 
A peristaltic pump, or other type fluid circulation device, is 
attached to inlet port 48 and outlet port 50. Media is then 45 
pumped through the top chamber. Diffusion grooves 46 allow 
even distribution of the fluid over the cells or construct. The 
same or a different media can also be perfused through the 
bottom chamber, from inlet port 36 through the chamber and 
out outlet port 36. The application of shear stress is continued 
for the desired time, which will vary, but can be for 3 to 14 
days, for example. 
50 varying flow rate or fluid viscosity. Other biomechanical 
stimuli include fluid-induced and direct-mechanical com-
The size of the top chamber can be changed by changing 
the size of the protrusion 44 or the thickness of the shim or the 
thickness of gasket 22. The size of the bottom chamber can be 55 
varied by changing the thickness of the frame 16 or the gasket 
32. 
pressive stress/pressurization. These mechanical signals can 
be static or cyclic in nature. 
The device can be designed to apply direct mechanical 
compression to the cells or construct by making the cap 
movable perpendicular to the cells/construct. Direct force can 
be constant or oscillatory. 
The rate of fluid flow through the device can be varied to 
control two functions: 1) rate of nutrient delivery and 2) 
amount of shear stress. The formula for shear stress via per-
fusion in a parallel-plate flow chamber is governed by the 
following formula: 
-c~6µQ/wh2 
where i: is the shear stress, µ is the media viscosity, Q is 
flow rate, w is chamber width and his height of flow channel. 
Thus, it can be seen that the desired shear stress can be 
A combination of biochemical and biomechanical stimuli 
60 may be most desirable. 
Scaffold 
If a scaffold is used, it could be placed in the top chamber, 
supported by the membrane, in order to maintain a distinct top 
and bottom compartment. Also, the scaffold could be placed 
65 in (what would be) the bottom compartment without a mem-
brane to allow for a more co-culture/composite construct to 
be cultured. 
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EXAMPLE 
The example below serves to further illustrate the inven-
tion, to provide those of ordinary skill in the art with a com-
plete disclosure and description of how the compounds, com-
positions, articles, devices, and/or methods claimed herein 
are made and evaluated, and is not intended to limit the scope 
of the invention. In the example, unless expressly stated oth-
erwise, amounts and percentages are by weight, temperature 
is in degrees Celsius or is at ambient temperature, and pres- 10 
sure is at or near atmospheric. The example is not intended to 
restrict the scope of the invention. 
Example 1 
Growth of Chondrocytes 
This experiment shows that chondrocytes can be cultured 
in the bioreactor and the resulting construct exhibits an 
increase in type II collagen and mechanical strength after 
15 
application of shear stress via perfusion. 20 
The bioreactor had a top chamber 1.8 inches long and 0.5 
inches wide; the growth area was 5.8 cm2 . The cells were 
primary 2 to 4 week old bovine articular chondrocytes. The 
cells were plated at high densities (2x 106 cells/cm2 ) in the top 
chamber of the bioreactor onto a porous, thin (10 micron), 25 
semipermeable (0.2 micron) polycarbonate membrane. 
The cells were statically cultured for 2 weeks in a DMEM 
base media, supplemented with 10% fetal bovine serum 
(FBS), non-essential amino acids, ascorbic acid and genta-
mycin sulfate, and then subjected to shear stress (about 15 30 
dynes/cm2 ) for 72 hrs in the bioreactor using perfusion. The 
flow rate was approximately 20 mL/min. 
Results 
Histological analysis showed the up-regulation of type II 
collagen after perfusion, with no substantial change in type I 35 
collagen. Type II collagen is the predominant type in carti-
lage. Histology also showed tissue heterogeneity. The Athro-
gen-CIA (Chondrex, Inc.) enzyme-linked immunosorbent 
assay (ELISA) showed a quantitative increase in type II col-
lagen. Mechanical testing showed a functional increase in 40 
Young's modulus after perfusion. 
8 
Modifications and variations of the present invention will 
be apparent to those skilled in the art from the forgoing 
detailed description. All modifications and variations are 
intended to be encompassed by the following claims. All 
publications, patents, and patent applications cited herein are 
hereby incorporated by reference in their entirety. 
What is claimed is: 
1. A bioreactor for culturing cells or conditioning a tissue 
construct, comprising: 
a frame to which a cell growth substrate or tissue construct 
can be attached; 
first and second growth or conditioning chambers on each 
side of the frame, wherein the chambers are separate 
when the substrate or construct is attached to the frame; 
a separate fluid supply for each chamber; 
diffusion grooves connected with the fluid supply in the 
first chamber so that fluid flowing through the fluid 
supply into the chamber applies shear stress to the cells 
or tissue in the chamber; and 
inlet and outlet tubes, each having a plurality of diffusion 
ports along its length, connected to the fluid supply of 
the second chamber. 
2. The bioreactor of claim 1, further comprising a cell 
growth substrate attached to the frame, wherein the substrate 
is a membrane or a scaffold to which cells can attach. 
3. The bioreactor of claim 1, wherein the bioreactor can be 
operated in static mode or dynamic mode. 
4. The bioreactor of claim 1, having a top chamber defined 
by a cap, a gasket, and the frame and a bottom chamber 
defined by a bottom plate, a gasket, and the frame, 
wherein each of the chambers has an inlet and outlet port 
for fluid flow through the chamber, 
wherein the diffusion grooves are in the top chamber cap 
and connected with the inlet and outlet ports so that the 
fluid supply through the chamber applies shear stress to 
the cells or tissue in the chamber; and 
wherein the cap of the top chamber seals tightly to the 
gasket and frame so that fluid can be passed through the 
chamber under pressure. 
* * * * * 
